Profil
David Bejker is currently Chief Executive Officer at Affibody Medical AB since 2018.
He is an Independent Director at Abliva AB since 2017.
He is also a Director at Amylonix AB and Disruptive Pharma Holding AB. Formerly, Mr. Bejker was Chief Executive Officer & Director at Affibody AB from 2003 to 2005.
Other former roles include Deputy Director at Nexstim Oyj, Independent Director at LIDDS AB, and Principal at HealthCap AB. Education includes graduate studies at Stockholm School of Economics.
Aktive Positionen von David Bejker
| Unternehmen | Position | Beginn |
|---|---|---|
| ABLIVA AB | Direktor/Vorstandsmitglied | 27.04.2017 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Vorstandsvorsitzender | 01.12.2018 |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Direktor/Vorstandsmitglied | - |
Disruptive Pharma Holding AB | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Bejker
| Unternehmen | Position | Ende |
|---|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Vorstandsvorsitzender | 01.07.2005 |
| LIDDS AB | Direktor/Vorstandsmitglied | - |
| NEXSTIM PLC | Corporate Officer/Principal | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Ausbildung von David Bejker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Abliva AB
Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexstim Oyj
Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology | Health Technology |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Health Technology |
Disruptive Pharma Holding AB |
















